Verition Fund Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-278,400
Closed -$1.96M 2999
2025
Q4
$1.96M Sell
278,400
-5,369
-2% -$32.4K 0.01% 1641
2025
Q3
$1.56M Sell
283,769
-169,246
-37% -$829K 0.01% 2173
2025
Q2
$2.34M Buy
453,015
+409,270
+936% +$2.45M 0.01% 1803
2025
Q1
$291K Sell
43,745
-29,948
-41% -$228K ﹤0.01% 2878
2024
Q4
$543K Buy
+73,693
New +$529K ﹤0.01% 2431
2024
Q3
Sell
-50,476
Closed -$248K 3377
2024
Q2
$248K Sell
50,476
-46,648
-48% -$281K ﹤0.01% 2465
2024
Q1
$599K Buy
+97,124
New +$654K ﹤0.01% 1915
2023
Q4
Sell
-29,700
Closed -$204K 2529
2023
Q3
$204K Buy
29,700
+13,376
+82% +$108K ﹤0.01% 1969
2023
Q2
$149K Sell
16,324
-239
-1% -$1.99K ﹤0.01% 1916
2023
Q1
$123K Buy
+16,563
New +$91.8K ﹤0.01% 1888

Other funds holding LFST

Verition Fund Management's LFST Position: Q1 2026 in Review

Verition Fund Management sold out of Lifestance Health (LFST) in Q1 2026, closing a stake of 278,400 shares — an estimated $1.96M sold.

Verition Fund Management first reported a position in LFST in Q1 2023 and held it in 10 quarters. The position peaked at $2.34M in Q2 2025. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Verition Fund Management reported no remaining Lifestance Health position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 278,400 Lifestance Health shares in Q1 2026, an estimated $1.96M.
  • Verition Fund Management first reported a position in Lifestance Health in Q1 2023 and held it in 10 quarters.
  • Verition Fund Management's Lifestance Health position peaked at $2.34M in Q2 2025.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.